Acknowledging Continuing Excellence (ACE) reporting

Acknowledging Continuing Excellence (ACE) was first introduced in the 2019 Annual SHOT Report and as a reporting category in 2021, with the dual aim of recognising exceptional practice by teams or departments and innovative solutions to previous adverse events.

See the guide on how to report ACE cases. (172kB pdf)

See more information on the importance of learning from excellence.

Reporting in this category will not be included in participation data for Serious Adverse Events (SAE) and Serious Adverse Reactions (SAR). All SAE/SAR must also be reported to SABRE and SHOT as normal.

ACE Definition

Exceptional transfusion practice by a team or department, that was above and beyond routine practice and has widespread learning opportunities.

Please do not name individuals within reports, the staff group (e.g., BMS, or Transfusion Practitioner) should be used where required.
All reports should have been discussed and agreed at the Hospital Transfusion Team/Committee (HTT/HTC) level before submitting to SHOT.

NB – SHOT encourage local processes to be put in place to recognise excellent contributions by individuals and sharing best practices between teams. Please focus on team or departmental excellence and avoid individual compliments unless they have widespread learning opportunities.

What to report

This category currently includes excellence within:

Transfusion Practice – Clinical
Transfusion Practice – Laboratory
Educational and Research
Audit
Patient or public engagement
Teamwork and collaboration

Examples include:

Innovative solutions to previous adverse events (all SAE/SAR must also be reported to SABRE and SHOT as normal)
Implementation of new procedures with positive patient outcomes
Multidisciplinary collaboration and communication
Patient involvement in agreeing individual transfusion treatment plans